Danicopan as Add-on Therapy to a C5 Inhibitor in Paroxysmal Nocturnal Hemoglobinuria (PNH) Participants Who Have Clinically Evident Extravascular Hemolysis (EVH)(ALPHA)

Research Site, Taipei

Research Site, New York

Research Site, Bangkok

Research Site, Athens

Research Site, Suwon

Research Site, Milan

Research Site, Madrid

Research Site, Majadahonda

Research Site, Haifa

Research Site, Weston

Research Site, Pessac

Research Site, Daejeon

Research Site, Las Palmas de Gran Canaria

Research Site, Bassano del Grappa

Research Site, Seville

Research Site, Kalamazoo

Research Site, Florence

Research Site, Milwaukee

Research Site, Thessaloniki

Research Site, Lille

Research Site, Chicago

Research Site, Pierre-Bénite

Research Site, Paris

Research Site, Dallas

Research Site, Avellino

Research Site, Kota Kinabalu

Research Site, Ulm

Research Site, Reggio Calabria

Research Site, Los Angeles

Research Site, Jerusalem

Research Site, Kuching

Research Site, Miri

Research Site, Rio de de Janeiro

Research Site, Belém

Research Site, Curitiba

Research Site, Goiânia

Research Site, Porto Alegre

Research Site, Toronto

Research Site, Brno

Research Site, Roma

Research Site, Bunkyō City

Research Site, Fukuoka

Research Site, Kashiwa-shi

Research Site, Kyoto

Research Site, Nagakute-shi

Research Site, Ogaki-shi

Research Site, Osaka

Research Site, Sayama

Research Site, Shibuya-ku

Research Site, Tanabe-shi

Research Site, Toyoake-shi

Research Site, Tsukuba

Research Site, Maastricht

Research Site, Gdansk

Research Site, Seoul

Research Site, Seoul

Research Site, Seoul

Research Site, Barcelona

Research Site, Barcelona

Research Site, Airdrie

Research Site, Leeds

Research Site, London